FDA 对 NexoBrid 的批准是基于多项临床前和临床研究,包括关键性3期美国临床研究 (DETECT),该...查看全文
F1watch2022-11-11 05:20
F-1 - MediWound Ltd. (0001593984) (Filer) Filed: 2022-11-10 AccNo: 0001178913-22-003933 Size: 893 KB 网页链接查看全文
usbiostock2018-06-11 22:44
$MediWound Ltd. - Ordinary Shares(MDWD)$ 公司完成DETECT临床3期试验病人入组,一线数据预计在2018年底公布。该试验旨在评估NexoBrid去除烧伤焦痂的疗效和安全性。查看全文
深思远见2015-08-11 20:14
$MediWound(MDWD)$近期评级信息如下:
20150805 Oppenheimer 重申相同投资评价, 评级:买入, 目标价:$13.00
更多分析和资讯,请关注微-信-公-众-号 stock_tong查看全文
GALLEONWANG2014-05-08 19:28
$MediWound(MDWD)$ 最起码有一款药物已经投放欧洲市场,值得关注。看看很多公司药物研发还在PHASE2 、PHASE 3, 相比之下 ,MEDIWOUND还是不错的, 也是值得考虑的查看全文
GALLEONWANG2014-05-08 19:26
$MediWound(MDWD)$ MediWound Expands Distribution of NexoBrid to Russia Through Agreement With Genfa Medica 网页链接查看全文
凤凰网港股|Kaken制药公司早些时候宣布,它已经向日本厚生劳动省提交了一份新药申请,以寻求KMW-1的生产和销售许可,用于清除烧伤疤痕。 2016年4月,Kaken与MediWound(MDWD)签订了独家许可协议,并开发了KMW-1,在某些国家以NexoBrid的品牌... 网页链接
$MediWound(MDWD)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001193125-19-039173 Size: 86 KB 网页链接
$MediWound(MDWD)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0001178913-19-000381 Size: 110 KB 网页链接
$MediWound(MDWD)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0000902219-19-000059 Size: 37 KB 网页链接
$MediWound(MDWD)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-11 AccNo: 0001213900-19-002073 Size: 136 KB 网页链接
$MediWound(MDWD)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-06 AccNo: 0001178913-19-000309 Size: 78 KB 网页链接
$MediWound(MDWD)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-01-22 AccNo: 0001178913-19-000121 Size: 64 KB 网页链接
$MediWound Ltd. - Ordinary Shares(MDWD)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-11-13 AccNo: 0001178913-18-002903 Size: 1 MB 网页链接
$MediWound Ltd. - Ordinary Shares(MDWD)$ 美东时间 2018-11-13 盘前 披露财报,预期EPS -0.19 网页链接
$MediWound Ltd. - Ordinary Shares(MDWD)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-09-24 AccNo: 0001178913-18-002568 Size: 36 KB 网页链接
$MediWound Ltd. - Ordinary Shares(MDWD)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-07 AccNo: 0001178913-18-002304 Size: 2 MB 网页链接